Dr. Ronald A. DePinho is a distinguished university professor and past president at MD Anderson Cancer Center. Ron is a global health leader, entrepreneur, physician and leading scientist in the fields of cancer and aging. In addition to his research, he has launched 3 biotech companies (Tvardi, Asylia, and Nirogy) focused on cancer, inflammation and fibrosis, with potential applications to COVID-19.

He specializes in strategic planning and financial analysis, clean energy technologies, energy and water issues, and international and governmental policies. From 2006 to 2010, he was director of the Strategic Energy Analysis Center at NREL. In addition to his NREL responsibilities, he is an author and expert reviewer for the Intergovernmental Panel on Climate Change (IPCC) Special Report on Renewable Energy and a member of the U.S. government review panel for the IPCC reports on climate change.

Prior to joining NREL, he was a management consultant to clean energy companies, providing strategy, development, and market counsel. Previous positions include: director of strategic marketing and business development at Network Photonics; director of media gateway products and strategic planning manager at Lucent Technologies (now Avaya); and vice president of business development for Amonix Inc.

Read More